These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35034581)

  • 1. The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients.
    Xing Y; Zhang X; Qin F; Yang J; Ai L; Wang Q; Zhai Y
    Bioengineered; 2022 Feb; 13(2):2130-2138. PubMed ID: 35034581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer.
    Liu X; Yan X; Li J; Mao W; Jiang F
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study.
    Gemenetzis G; Groot VP; Yu J; Ding D; Teinor JA; Javed AA; Wood LD; Burkhart RA; Cameron JL; Makary MA; Weiss MJ; He J; Wolfgang CL
    Ann Surg; 2018 Sep; 268(3):408-420. PubMed ID: 30080739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
    Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
    Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION.
    Gasparini-Junior JL; Fanelli MF; Abdallah EA; Chinen LTD
    Arq Bras Cir Dig; 2019; 32(2):e1433. PubMed ID: 31038558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis.
    Tao L; Zhang L; Peng Y; Tao M; Li L; Xiu D; Yuan C; Ma Z; Jiang B
    Medicine (Baltimore); 2016 Sep; 95(39):e4932. PubMed ID: 27684834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer.
    Chen K; Chen Z; Ou M; Wang J; Huang X; Wu Y; Zhong W; Yang J; Huang J; Huang M; Pan D
    Clinics (Sao Paulo); 2022; 77():100070. PubMed ID: 36087570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma.
    Wang Z; Zhang P; Chong Y; Xue Y; Yang X; Li H; Wang L; Zhang Y; Chen Q; Li Z; Xue L; Li H; Chong T
    Dis Markers; 2021; 2021():9956142. PubMed ID: 34733376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
    Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
    Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.
    Tseng JY; Yang CY; Liang SC; Liu RS; Yang SH; Lin JK; Chen YM; Wu YC; Jiang JK; Lin CH
    Clin Cancer Res; 2014 Jun; 20(11):2885-97. PubMed ID: 24677375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
    Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
    Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
    Sun B; Liu H; Wang S; Xiang J; Liu X
    J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-Small-Cell Lung Cancer.
    Ye L; Zhang F; Li H; Yang L; Lv T; Gu W; Song Y
    Dis Markers; 2017; 2017():5727815. PubMed ID: 29434410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer.
    Wei T; Zhang X; Zhang Q; Yang J; Chen Q; Wang J; Li X; Chen J; Ma T; Li G; Gao S; Lou J; Que R; Wang Y; Dang X; Zheng L; Liang T; Bai X
    Cancer Lett; 2019 Jun; 452():237-243. PubMed ID: 30905814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.